Other: 3-days water-fasting ( DrugBank: Water )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 67 | Polycystic kidney disease | 1 |
67. Polycystic kidney disease
Clinical trials : 216 / Drugs : 219 - (DrugBank : 50) / Drug target genes : 39 - Drug target pathways : 151
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04680780 (ClinicalTrials.gov) | January 10, 2021 | 1/10/2020 | Ketogenic Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Ketogenic Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease (ADPKD) | ADPKD | Other: Ketogenic diet;Other: 3-days water-fasting;Other: Control | University of Cologne | NULL | Active, not recruiting | 18 Years | 60 Years | All | 63 | N/A | Germany |